Cargando…

Global priorities for large-scale biomarker-based prospective cohorts

The focus of this paper is on strategic approaches for establishing population-based prospective cohorts that collect and store biological samples from very large numbers of participants to help identify the determinants of common health outcomes. In particular, it aims to address key issues related...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Rory, Balaconis, Mary K., Brunak, Søren, Chen, Zhengming, De Silva, Mary, Gaziano, J. Michael, Ginsburg, Geoffrey S., Jha, Prabhat, Kuri, Pablo, Metspalu, Andres, Mulder, Nicola, Risch, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903754/
https://www.ncbi.nlm.nih.gov/pubmed/36778137
http://dx.doi.org/10.1016/j.xgen.2022.100141
_version_ 1784883521439924224
author Collins, Rory
Balaconis, Mary K.
Brunak, Søren
Chen, Zhengming
De Silva, Mary
Gaziano, J. Michael
Ginsburg, Geoffrey S.
Jha, Prabhat
Kuri, Pablo
Metspalu, Andres
Mulder, Nicola
Risch, Neil
author_facet Collins, Rory
Balaconis, Mary K.
Brunak, Søren
Chen, Zhengming
De Silva, Mary
Gaziano, J. Michael
Ginsburg, Geoffrey S.
Jha, Prabhat
Kuri, Pablo
Metspalu, Andres
Mulder, Nicola
Risch, Neil
author_sort Collins, Rory
collection PubMed
description The focus of this paper is on strategic approaches for establishing population-based prospective cohorts that collect and store biological samples from very large numbers of participants to help identify the determinants of common health outcomes. In particular, it aims to address key issues related to investigation of genetic, as well as social, environmental, and ancestral, diversity; generation of detailed genetic and other types of assay data; collection of detailed lifestyle and environmental exposure information; follow-up and characterization of incident health outcomes; and overcoming obstacles to data sharing and access (including capacity building). It concludes that there is a need for strategic planning at an international level (rather than the current ad hoc approach) toward the development of a carefully selected set of deeply characterized large-scale prospective cohorts that are readily accessible by researchers around the world.
format Online
Article
Text
id pubmed-9903754
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99037542023-02-10 Global priorities for large-scale biomarker-based prospective cohorts Collins, Rory Balaconis, Mary K. Brunak, Søren Chen, Zhengming De Silva, Mary Gaziano, J. Michael Ginsburg, Geoffrey S. Jha, Prabhat Kuri, Pablo Metspalu, Andres Mulder, Nicola Risch, Neil Cell Genom Commentary The focus of this paper is on strategic approaches for establishing population-based prospective cohorts that collect and store biological samples from very large numbers of participants to help identify the determinants of common health outcomes. In particular, it aims to address key issues related to investigation of genetic, as well as social, environmental, and ancestral, diversity; generation of detailed genetic and other types of assay data; collection of detailed lifestyle and environmental exposure information; follow-up and characterization of incident health outcomes; and overcoming obstacles to data sharing and access (including capacity building). It concludes that there is a need for strategic planning at an international level (rather than the current ad hoc approach) toward the development of a carefully selected set of deeply characterized large-scale prospective cohorts that are readily accessible by researchers around the world. Elsevier 2022-06-08 /pmc/articles/PMC9903754/ /pubmed/36778137 http://dx.doi.org/10.1016/j.xgen.2022.100141 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Collins, Rory
Balaconis, Mary K.
Brunak, Søren
Chen, Zhengming
De Silva, Mary
Gaziano, J. Michael
Ginsburg, Geoffrey S.
Jha, Prabhat
Kuri, Pablo
Metspalu, Andres
Mulder, Nicola
Risch, Neil
Global priorities for large-scale biomarker-based prospective cohorts
title Global priorities for large-scale biomarker-based prospective cohorts
title_full Global priorities for large-scale biomarker-based prospective cohorts
title_fullStr Global priorities for large-scale biomarker-based prospective cohorts
title_full_unstemmed Global priorities for large-scale biomarker-based prospective cohorts
title_short Global priorities for large-scale biomarker-based prospective cohorts
title_sort global priorities for large-scale biomarker-based prospective cohorts
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903754/
https://www.ncbi.nlm.nih.gov/pubmed/36778137
http://dx.doi.org/10.1016/j.xgen.2022.100141
work_keys_str_mv AT collinsrory globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT balaconismaryk globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT brunaksøren globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT chenzhengming globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT desilvamary globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT gazianojmichael globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT ginsburggeoffreys globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT jhaprabhat globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT kuripablo globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT metspaluandres globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT muldernicola globalprioritiesforlargescalebiomarkerbasedprospectivecohorts
AT rischneil globalprioritiesforlargescalebiomarkerbasedprospectivecohorts